Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
LaQuita M. Jones
Observed names:
LaQuita Jones,
LaQuita M Jones,
LaQuita Marie Jones
Institution:
Cincinnati Children's Hospital Medical Center
Observed institutions:
Cincinnati Children's Hospital Medical Center,
Nationwide Children's Hospital,
University of Cincinnati
ORCID:
0000-0001-9877-9558
Observed ORCID:
0000-0001-9877-9558
OpenAlex ID:
A5079818733
Works
17
Awards
1
Overcoming adaptive therapy resistance in AML by targeting immune response pathways
2019
·
Katelyn Melgar
, Morgan M. Walker
, et al.
·
Science Translational Medicine
·
98
Targeting AML-associated FLT3 mutations with a type I kinase inhibitor
2020
·
LaQuita M. Jones
, Katelyn Melgar
, et al.
·
Journal of Clinical Investigation
·
46
PDF
Reducing emergency department visits utilizing a primary care asthma specialty clinic in a high-risk patient population
2017
·
Dane A. Snyder
, Olivia W. Thomas
, et al.
·
Journal of Asthma
·
20
Effect of osteopathic manipulative treatment on pulmonary function testing in children with asthma
2021
·
LaQuita M. Jones
, Christopher Regan
, et al.
·
Journal of Osteopathic Medicine
·
18
PDF
Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients
2024
·
Francis R. LeBlanc
, Erin H. Breese
, et al.
·
British Journal of Haematology
·
13
PDF
Targeted Therapy in Pediatric AML: An Evolving Landscape
2021
·
LaQuita M. Jones
, Katherine Tarlock
, et al.
·
Pediatric Drugs
·
13
Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid Leukemia
2024
·
Scott B. Hoyt
, Chris J. Finocchio
, et al.
·
ACS Medicinal Chemistry Letters
·
11
IRAK1/4/pan-FLT3 Kinase Inhibitors with Reduced hERG Block as Treatments for Acute Myeloid Leukemia
2025
·
Scott B. Hoyt
, Chris J. Finocchio
, et al.
·
ACS Medicinal Chemistry Letters
·
6
PDF
Patterns of Emergency Department Care for Newly Diagnosed Immune Thrombocytopenia in United States Children's Hospitals
2017
·
LaQuita Jones
, Terah Koch
, et al.
·
The Journal of Pediatrics
·
4
Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient
2018
·
LaQuita Jones
, Christopher Dandoy
, et al.
·
Bone Marrow Transplantation
·
3
An unusual cause of fever in a patient with common variable immunodeficiency
2017
·
Andrew T. Dang
, Gene Schwartz
, et al.
·
Annals of Allergy Asthma & Immunology
·
2
PDF
IKAROS and MENIN in synergy in AML
2022
·
LaQuita M. Jones
, Daniel T. Starczynowski
·
Nature Cancer
·
1
Overcoming Adaptive Therapy Resistance in AML By Targeting Immune Response Pathways
2019
·
Katelyn M. Melgar
, LaQuita M Jones
, et al.
·
Blood
·
1
81030 Utilizing a synergistic drug combination to target relapsed/refractory FLT3 mutant AML
2021
·
LaQuita Jones
, Katelyn Melgar
, et al.
·
Journal of Clinical and Translational Science
PDF
Methylation profiling of hypomethylating agent response and treatment failure in pediatric and young adult MDS/AML.
2020
·
LaQuita Marie Jones
, Maureen Megan O'Brien
, et al.
·
Journal of Clinical Oncology
Exceptional Responses to Epigenetic Based Therapy in Pediatric and Young Adult Monosomy 7 MDS/AML Patients with and without TP53 Mutations
2017
·
LaQuita M. Jones
, Maureen M. O’Brien
, et al.
·
Blood
A Case of Histoplasmosis and Renal Extranodal Marginal Zone Lymphoma in a Patient with Common Variable Immunodeficiency (CVID) and Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD)
2017
·
Andrew T. Dang
, Gene Schwartz
, et al.
·
Journal of Allergy and Clinical Immunology
PDF
Show more works
View as search
Works count:
17
Citation count:
236
H-index:
7
I10-index:
7
Year
Topic
Type